Back to User profile » Dr Sheng Jiang
Papers published by Dr Sheng Jiang:
KRT23 as a Potential Target for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): Evidence From Bioinformatics Analysis, Human Gene Polymorphism and Animal Experiments
Hao Y, Zhang T, Tuerxunmaimaiti S, Tian Y, Wang X, Li Z, Zhao L, Bai L, Chen Q, Li C, Abulitipu A, Wang R, Jiang S, Du G
International Journal of General Medicine 2025, 18:2807-2821
Published Date: 3 June 2025
The Dual Role and Therapeutic Implications of the Wnt/β-Catenin Pathway in Diabetic Kidney Disease
Adeerjiang Y, Gan XX, Li WT, Li QT, Jiang YQ, Zhu X, Hu CM, Wang PX, Jiang S
International Journal of General Medicine 2025, 18:2757-2768
Published Date: 28 May 2025
Evaluation of MASLD Fibrosis, FIB-4 and APRI Score in MASLD Combined with T2DM and MACCEs Receiving SGLT2 Inhibitors Treatment
Liu H, Hao YM, Jiang S, Baihetiyaer M, Li C, Sang GY, Li Z, Du GL
International Journal of General Medicine 2024, 17:2613-2625
Published Date: 5 June 2024
Development and External Validation of Nomogram to Identify Risk Factors for CHD in T2DM in the Population of Northwestern China
Meng Q, Yang J, Wang F, Li C, Sang G, Liu H, Shen D, Zhang J, Jiang S, Yusufu A, Du G
Diabetes, Metabolic Syndrome and Obesity 2023, 16:1271-1282
Published Date: 4 May 2023